<DOC>
	<DOCNO>NCT01213758</DOCNO>
	<brief_summary>Patients treat stereotactic radiotherapy liver tumor undergo PET/CT use galactose analogue 18-F-deoxy-galactose ( FDGal ) radiotherapy . This technique provide volumetric map liver function allow quantisation liver function . The method may use selection patient stereotactic radiotherapy liver tumor , determination radiation induce liver dysfunction may include treatment plan process stereotactic radiotherapy .</brief_summary>
	<brief_title>Changes Liver Function After Stereotactic Body Radiation Therapy Measured PET/CT</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>liver tumor refer stereotactic radiation therapy age &gt; 18 year Impaired kidney function Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>liver function</keyword>
	<keyword>galactose</keyword>
	<keyword>18-F-deoxy-galactose</keyword>
	<keyword>PET/CT</keyword>
	<keyword>stereotactic body radiation therapy</keyword>
	<keyword>SBRT</keyword>
</DOC>